Sundrug reports strong first-half sales, profit growth

Sundrug Co., Ltd. reported a 5.8% increase in net sales to 418,437 million yen for the six months ended September 30, 2025, compared to the same period last fiscal year. Operating profit rose by 8.7% to 23,057 million yen, while ordinary profit climbed 9.9% to 22,893 million yen. Profit attributable to owners of parent increased by 7.0% to 15,269 million yen.

The Drugstore Business segment saw net sales reach 267,028 million yen, up 4.5%, with operating profit at 13,283 million yen, an increase of 5.1%. The Discount Store Business segment also performed strongly, with net sales growing 8.0% to 181,822 million yen and operating profit soaring 14.1% to 9,774 million yen. These gains were supported by higher unit prices in food products and improved transaction conditions.

Total assets grew by 6,613 million yen to 450,620 million yen as of September 30, 2025, primarily due to increases in merchandise and property, plant, and equipment from new store openings and renovations. Net assets increased by 7,744 million yen to 277,458 million yen. The company reiterated its full-year consolidated financial results forecast, which remains unchanged from May 15, 2025.